NCT00566527 Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) Status COMPLETED Phase PHASE3
NCT00566267 A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet Status COMPLETED Phase PHASE2/PHASE3
NCT00565292 A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00565084 Tolerability and Efficacy of Ibuprofen 800 mg in a Walking Model of Osteoarthritis Pain (0000-057) Status COMPLETED Phase PHASE1
NCT00565006 A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00564447 Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers Status COMPLETED Phase PHASE4
NCT00564421 Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648) Status COMPLETED Phase PHASE3
NCT00562510 Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery Status TERMINATED Phase PHASE3
NCT00561821 Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709) Status COMPLETED Phase PHASE3
NCT00561574 A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001) Status COMPLETED Phase PHASE3
NCT00561418 Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma Status COMPLETED Phase PHASE1
NCT00561327 PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites Status UNKNOWN Phase N/A
NCT00561080 Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043) Status COMPLETED Phase PHASE3
NCT00560950 Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007) Status COMPLETED Phase PHASE3
NCT00560833 Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012) Status COMPLETED Phase PHASE3
NCT00559468 Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028) Status COMPLETED Phase PHASE3